Sponsor pipeline

Eva Morava-Kozicz clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 1		1
Phase 2		3

NCT ID	Title	Condition	Status	Updated
Phase 2
NCT05402345	A Study of GlcNAc on Tear Production in NGLY1-CDDG	NGLY1 Deficiency	Active, Not Recruiting	2026-09-29
NCT05402384	AVTX-801 D-galactose Supplementation in SLC35A2-CDG	SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation	Not Yet Recruiting	2026-06-29
NCT05402332	Evaluating the Efficacy and Safety of D-galactose in PGM1-CDG (AVTX-801)	PGM1-CDG - Phosphoglucomutase 1-Related Congenital Disorder of Glycosylation	Not Yet Recruiting	2026-03-16
Phase 1
NCT07572825	Assessing the Safety and Tolerability of NMN in DHDDS-CDG	DHDDS-Congenital Disorder of Glycosylation	Recruiting	2026-06-22

Get alerts when Eva Morava-Kozicz's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.